ReviewOpen Access
Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
Authors
Author Affiliations
Indian Veterinary Research Institute, Trafford College, Punjab Agricultural University, University of Dhaka, ...
Published InHuman Vaccines & Immunotherapeutics
Year2022
Citations236
Abstract
Autoimmune diseases are caused when immune cells act against self-protein. This biological self-non-self-discrimination phenomenon is controlled by a distinct group of lymphocytes known as regulatory T cells (Tregs), which are key inflammatory response regulators and play a pivotal role in immune tolerance and homeostasis. Treg-mediated robust immunosuppression provides self-tolerance and protection against autoimmune diseases. However, once this system fails to operate or poorly operate, it leads to an extreme situation where immune system reacts against self-antigens and destroys host organs, thus causing autoimmune diseases. Tregs can target both innate and adaptive immunity via modulating multiple immune cells such as neutrophils, monocytes, antigen-presenting cells, B cells, and T cells. This review highlights the Treg-mediated immunosuppression, role of several markers and their…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.